Catalyst Wire Dossier Catalyst Wire Dossier

IQP-AS-105

· InQpharm Group
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IQP-AS-105, covering 2016-02-12 to 2016-02-12. Get the full timeline:

Most recent: Clinical Trial Update: Benefit and Tolerability of IQP-AS-105 in Reducing Susceptibility to Upper Respiratory Tract Infections [Phase 3]

See pricing